KRAS G12C inhibitors in metastatic colorectal cancer: a tale of two targets
Funding: None.
| Authors: | , |
|---|---|
| Format: | article |
| Status: | Published version |
| Publication Date: | 2024 |
| Country: | España |
| Institution: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repository: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/403671 |
| Online Access: | http://hdl.handle.net/10261/403671 https://api.elsevier.com/content/abstract/scopus_id/85207390844 |
| Access Level: | Open access |
| Keyword: | KRAS G12C Metastatic colorectal cancer (mCRC) RAS-mutant Epidermal growth factor receptor (EGFR) Target therapy |
| Summary: | Funding: None. |
|---|